At Caris Life Sciences®, we are committed to providing our clients – both physician and patient – with the very best service. If, at any point, you have questions about the capabilities and/or procedures of our Molecular Intelligence™ Service, Caris' dedicated Client Services team is on-hand to assist you at every step of the process.
Client Services: 1.888.979.8669
- Hours of operation: Monday – Friday, 7:30 AM – 7:30 PM (CST)
- Fax: 1.866.479.4925
Main Switchboard: 1.866.771.8946
Billing Services: 1.877.630.6223
- Hours of operation: Monday – Friday, 7:00 AM – 4:30 PM (CST)
- Fax: 1.214.294.5690
- Billing Inquiries
Please have your account number (found on your bill) and insurance policy number (from your insurance card) available.
Our experienced Client Services team can assist with all issues relating to Molecular Intelligence Service ordering, including:
- Logistics/courier pick up
- Testing methods and turn-around time (TAT)
- Sample requirements and shipper kits
- Report delivery, status or interpretation
- Expert oncology and pathology consultations
- Requests for evidence references
- Physician or patient education materials
Other Forms & Tools:
Molecular Intelligence™ Service, from Caris Life Sciences®, provides evidence-based tumor information that associates biomarker status to agents with potential clinical benefit or potential lack of clinical benefit. Agents associated with clinical benefit are presented based on NCCN Compendium™ inclusion, relevance of tumor type, level of published evidence and strength of biomarker expression. Report information must be considered in conjunction with all other relevant information in respect of a given patient before determining the appropriate course of treatment. The selection of agents for re-treatment from prior chemotherapy regimens lies with the treating physician and must be done with careful consideration. Caris Molecular Intelligence Service was developed and its performance characteristics were determined by Caris Life Sciences, a medical laboratory CLIA-certified in compliance with the U.S. Clinical Laboratory Amendment Act of 1988 and all relevant U.S. state regulations. Caris Molecular Intelligence Service has not been approved by the United States Food and Drug Administration.